|
Feb 29
|
Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
|
|
Jan 1
|
Institutions own 30% of Arbutus Biopharma Corporation (NASDAQ:ABUS) shares but individual investors control 32% of the company
|
|
Nov 8
|
Arbutus to Present at Jefferies London Healthcare Conference
|
|
Nov 8
|
Q3 2023 Arbutus Biopharma Corp Earnings Call
|
|
Nov 7
|
Arbutus Biopharma Corp (ABUS) Reports Q3 2023 Financial Results
|
|
Nov 7
|
Arbutus Reports Third Quarter 2023 Financial Results and Provides Corporate Update
|
|
Nov 7
|
Arbutus Announces CEO, William Collier, to Retire December 31, 2023
|
|
Aug 26
|
Arbutus Biopharma (NASDAQ:ABUS) shareholders have endured a 78% loss from investing in the stock five years ago
|